Skip to main content
SpringerLink
Log in

Cell Death, Tissue Hypoxia and the Progression of Heart Failure

  • Published:
Heart Failure Reviews Aims and scope Submit manuscript

Abstract

An important feature of heart failure is the progressive deterioration of left ventricular function that occurs in the absence of clinically apparent intercurrent adverse events. The mechanism or mechanisms responsible for this hemodynamic deterioration are not known. We and others have advanced the hypothesis that this hemodynamic deterioration results from progressive intrinsic contractile dysfunction of viable cardiomyocytes and/or from ongoing loss of cardiomyocytes. This review will focus on the concept of ongoing cardiac myocyte loss as a contributing factor to the progression of left ventricular dysfunction that characterizes the heart failure state. Specifically, the discussion will center on apoptosis or “programmed cell death” as a potential mediator of cardiomyocyte loss. In recent years, several studies have shown that constituent myocytes of failed explanted human hearts and hearts of animals with experimentally induced heart failure undergo apoptosis. Studies have also shown that cardiomyocyte apoptosis occurs following acute myocardial infarction, in the hypertrophied heart as well as in the aging heart; conditions frequently associated with the development of failure. While available data support the existence of myocyte apoptosis in the failing heart, lacking are studies which address the importance of myocyte apoptosis in the progression of LV dysfunction. As part of this discussion, we will address this issue and construct a case in support of a concept that the failing myocardium is subject to regional hypoxia, an abnormality that can potentially trigger cardiomyocyte apoptosis. If loss of cardiac myocytes through apoptosis can be shown to be an important contributor to the progression of heart failure, and if exact physiologic and molecular factors that trigger apoptosis in the heart can be identified, the stage will be set for the development of novel therapeutic modalities aimed at preventing, or at the very least retarding, the process of progressive ventricular dysfunction and the ultimate transition toward end-stage, intractable heart failure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Mckee PA, Castelli WP, Mcnamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971;285:1441–1446.

    Google Scholar 

  2. Konstam MA, Rousseau MF, Kronenberg MW, Udelson JE, Melin J, Stewart D, Dolan N, Edens TR, Ahn S, Kinan D, Howe DM, Kilcoyne L, Metherall J, Benedict C, Yusuf S, Pouleur H. Effects of the angiotensin converting enzyme inhibitor enalapril on long-term progression of left ventricular dysfunction in patients with heart failure. Circulation 1992;86:431–438.

    Google Scholar 

  3. Levine TB, Francis GS, Goldsmith SR, Simon AB, Cohn JN. Activity of the sympathetic nervous system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. Am J Cardiol 1982;49:1659–1666.

    Google Scholar 

  4. Curtiss C, Cohn JN, Vrobel T, Franciosa JA. Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failure. Circulation 1978;58:763–770.

    Google Scholar 

  5. Sabbah HN, Sharov VG, Riddle JM, Kono T, Lesch M, Goldstein S. Mitochondrial abnormalities in myocardium of dogs with chronic heart failure. J Mol Cell Cardiol 1992;24:1333–1347.

    Google Scholar 

  6. Sharov VG, Sabbah HN, Shimoyama H, Ali AS, Levine TB, Lesch M, Goldstein S. Abnormalities of contractile structures in viable myocytes of the failing heart. Intl J Cardiol 1994;43:287–297.

    Google Scholar 

  7. Schaper J, Hein S. The structural correlate of reduced cardiac function in human dilated cardiomyopathy. Heart Failure 1993;9:95–111.

    Google Scholar 

  8. Sabbah HN, Sharov VG, Lesch M, Goldstein S. Progression of heart failure: A role for interstitial fibrosis. Mol Cell Biochem 1995;147:29–34.

    Google Scholar 

  9. Perennec J, Hatt PY. Myocardial morphology in cardiac hypertrophy and failure: electron microscopy in man. In: Swynghedauw B, ed. Cardiac hypertrophy and failure. London: John Libbey Eurotext; 1988:267–276.

    Google Scholar 

  10. Kunkel B, Lapp H, Kober G, Kaltenback M. Ultrastructural evaluations in early and advanced congestive cardiomyopathy. In: Kaltenback M, Loogen F, Olsen EGJ, eds. Cardiomyopathy and cardiac biopsy, New York, NY; 1978;87-99.

  11. Sharov VG, Sabbah HN, Shimoyama H, Goussev A, Lesch M, Goldstein S. Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure. Am J Pathol 1996;148:141–149.

    Google Scholar 

  12. Narula J, Haider N, Virmani R, DiSalvo TG, Kolodgie FD, Hajjar RJ, Schmidt U, Semigran MJ, Dec GW, Khaw BA. Apoptosis in myocytes in end-stage heart failure. N Engl J Med 1996;335;1182–1189.

    Google Scholar 

  13. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, Quaini E, Di Loreto C, Beltrami A, Krajewski S, Reed JC, Anversa P. Apoptosis in the failing human heart. N Engl J Med 1996;336:1131–1141.

    Google Scholar 

  14. Kerr JFR, Wylle AH, Curie AR. Apoptosis: a basic biological phenomenon with widespread implication in tissue kinetics. Br J Cancer 1972;26:239–257.

    Google Scholar 

  15. Barr PJ, Tomei LD. Apoptosis and its role in human disease. Bio/Technology 1994;12:487–493.

    Google Scholar 

  16. Anversa P, Fitzpatrick D, Argani S, Capasso JM. Myocyte mitotic division in the aging mammalian rat heart. Circ Res 1991;69:1159–1164.

    Google Scholar 

  17. Liu Y, Cigola E, Cheng W, Kajstura J, Olivetti G, Hintze TH, Anversa P. Myocyte nuclear mitotic division and programmed myocyte cell death characterize the cardiac myopathy induced by rapid ventricular pacing in dogs. Lab Invest 1995;73:771–787.

    Google Scholar 

  18. Trump BF, Berezesky IK, Cowley RA. The cellular and subcellular characteristics of acute and chronic injury with emphasis on the role of calcium. In: Cowley RA, Trump BF, eds. Pathophysiology of shock, anoxia, and ischemia. Baltimore/London: Williams & Wilkins, 1982:6–46.

    Google Scholar 

  19. Jennings RB, Ganote CE. Structural changes in myocardium during acute ischemia. Circ Res 1974;34-35:1 27. 56–172.

    Google Scholar 

  20. Kerr JFR. Shrinkage necrosis: A distinct mode of cellular death. J Pathol 1971;105:13–20.

    Google Scholar 

  21. Savill J. Apoptosis in disease. Europ J Clin Invest 1994;24:715–723.

    Google Scholar 

  22. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456–1462.

    Google Scholar 

  23. Sabbah HN, Stein PD, Kono T, Gheorghiade M, Levine TB, Jafri S, Hawkins ET, Goldstein S. A canine model of chronic heart failure produced by multiple sequential coronary microembolizations. Am J Physiol 1991;260:H1379–H1384.

    Google Scholar 

  24. Sabbah HN, Sharov VG, Goussev A, Tanimura M, Mishima T, Lesch M, Goldstein S. Evidence for ongoing loss of cardiomyocytes in dogs with progressive left ventricular dysfunction and failure. Circulation 1997;96:1–754.

    Google Scholar 

  25. Sharov VG, Sabbah HN, Ali AS, Shimoyama H, Lesch M, Goldstein S. Abnormalities of cardiomyocytes in regions bordering fibrous scars in dogs with chronic heart failure. Int'l J Cardiol 1997;60:273–279.

    Google Scholar 

  26. Sharov VG, Goussev A, Higgins RSD, Silverman N, Lesch M, Goldstein S, Sabbah HN. Higher incidence of cardiocyte apoptosis in failed explanted hearts of patients with ischemic versus idiopathic dilated cardiomyopathy (Abstract). Circulation 1997;96:1–17.

    Google Scholar 

  27. Raff MC. Social controls on cell survival and cell death. Nature 1992;356:398–400.

    Google Scholar 

  28. Hockenberg D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990;348:334–336.

    Google Scholar 

  29. Allsopp TE, Wyatt S, Paterson HF, Davies AM. The proto-oncogene Bcl-2 can selectively rescue neutrophil factor-dependent neurons from apoptosis. Cell 1993;73:295–307.

    Google Scholar 

  30. MacLellan WR, Schneider MD. Death by design. Programmed cell death in cardiovascular biology and disease. Circ Res 1997;81:137–144.

    Google Scholar 

  31. Cheng W, Kajstura J, Nitahara JA, Li B, Reiss K, Liu Y, Clark WA, Krajewski S, Reed JC, Olivetti G, Anversa P. Programmed myocyte cell death affects the viable myocardium after infarction in rats. Exp cell Res 1996;226:316–327.

    Google Scholar 

  32. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 1993;362:786–787.

    Google Scholar 

  33. Wagner AJ, Kokontis JM, Hay N. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21 wafl/cipl. Genes Dev 1994;8:2817–2830.

    Google Scholar 

  34. Sharov VG, Sabbah HN, Goussev A, Undrovinas AI, Gupta RC, Lesch M, Goldstein S. Apoptosis associated proteins c-myc and p53 are expressed in cardiomyocytes isolated from dogs with chronic heart failure (Abstract). Circulation 1996;94:1–471.

    Google Scholar 

  35. Pabla R, Rees SA, Know KA, Powell T. Apoptosis is mediated by ICE-like proteases in ventricular myocytes (Abstract). Circulation 1986;94:1–282.

    Google Scholar 

  36. Bialik S, Geenen DL, Sasson IE, Valentine KL, Fritz LC, Kitsis RN. The caspase family of cysteine proteases mediate cardiac myocyte apoptosis during myocardial infarction (Abstract). Circulation 1997;96:1552.

    Google Scholar 

  37. Cahill MA, Peter ME, Kischkel FC, Chinnaiyan AM, Dixit VM, Krammer PH, Nordheim A. CD95 (APO-1/Fas) induces activation of SAP kinases downstream of ICE-like proteases. Oncogene 1996;13:2087–2096.

    Google Scholar 

  38. Evans GI, Brown L, Whyte M, Harrington E. Apoptosis and the cell cycle. Curr Opin Cell Biol 1995;7:825–834.

    Google Scholar 

  39. Meikrantz W, Schlegel R. Apoptosis and the cell cycle. J Biol Cem 1995;58:160–174.

    Google Scholar 

  40. Reiss K, Cheng W, Giorando A, DeLuca A, Li B, Kajstura J, Anversa P. Myocardial infarction is coupled with activation of cyclin and cyclin-dependent kinases in myocytes. Exp Cell Res 1996;225:44–54.

    Google Scholar 

  41. Orrenius S, McConkey DJ, Bellomo G, Nicotera P. Role of Ca2. in toxic cell killing. Trends Pharmacol Sci 1989;10:281–285.

    Google Scholar 

  42. Gottlieb RA, Burleson KO, Kloner RA, Babior BM, Engler RL. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clinic Invest 1994;94:1621–1628.

    Google Scholar 

  43. Tanaka M, Ito H, Adachi S, Akimoto H, Nishikawa T, Kasajima T, Marumo F, Hiroe M. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ Res 1994;75:426–433.

    Google Scholar 

  44. Kajstura J, Cigola E, Malhotra A, Li P, Cheng W, Meggs LG, Anversa P. Angiotensin II induces apoptosis of adult ventricular myocytes in vitro. J Mol Cell Cardiol 1997;29:859–870.

    Google Scholar 

  45. Goussev A, Sharov VG, Shimoyama H, Tanimura M, Lesch M, Goldstein S, Sabbah HN. Effects of ACE inhibition on cardiomyocyte apoptosis in dogs with heart failure. Am J Physiol 1998;275:H626–H631.

    Google Scholar 

  46. Communal C, Singh K, Pimentel DR, Colucci WS. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of ?-adrenergic pathway. Circulation 1998;98:1329–1334.

    Google Scholar 

  47. Sabbah HN, Sharov VG, Cook JM, Shimoyama H., Lesch M, Goldstein S. Enalapril but not metoprolol improves capillary density and oxygen diffusion distance in left ventricular myocardium of dogs with moderate heart failure (Abstract). J Am Coll Cardiol 1996;27:195A.

    Google Scholar 

  48. Shimoyama H, Sabbah HN, Sharov VG, Cook J, Lesch M, Goldstein S. Accumulation of interstitial collagen in the failing left ventricular myocardium is associated with increased anaerobic metabolism among affected cardiomyocytes (Abstract). J Am Coll Cardiol, Special Issue: 1994;98A.

  49. Laderoute KR, Webster KA. Hypoxia/reoxygenation stimulates Jun kinase activity through redox signaling in cardiac myocytes. Circ Res 1997;80:336–344.

    Google Scholar 

  50. Seko Y, Tobe K, Ueki K, Kadowaki T, Yazaki Y. Hypoxia and hypoxia/reoxygenation activate Raf-1, mitogen-activated protein kinase kinase, mitogenactivated protein kinase, and S6 kinase in cultured rat cardiac myocytes. Circ Res 1996;78:82–90.

    Google Scholar 

  51. Sharov VG, Goussev A, Higgins RSD, Silverman N, Goldstein S, Sabbah HN. Exposure to hypoxia and angiotensin-II increases the expression of mitogen activated protein kinase in cardiomyocytes isolated from explanted failed human hearts (Abstract). J Am Coll Cardiol 1999;33:182A.

    Google Scholar 

  52. Sharov VG, Todor A, Mishra S, Mishima T, Suzuki G, Goldstein S, Sabbah HN. Inhibition of p38 ?/? MAPK attenuates hypoxia-mediated and angiotensin-IImediated apoptosis in cardiomyocytes isolated from dogs with chronic heart failure (Abstract). J Am Coll Cardiol 2000;35:169A.

    Google Scholar 

  53. Long X, Crow MT, Lakatta EG. Ice-related proteases are involved in hypoxia-induced apoptosis in cardiac myocytes. Circulation 1997;96:1737.

    Google Scholar 

  54. Webster KA, Discher DJ, Bishopric NH. Induction and nuclear accumulation of Fos and Jun proto-oncogenes in hypoxic cardiac myocytes. J Biol Chem 1993;268:16852–16858.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Cardiovascular Medicine, Henry Ford Heart & Vascular Institute, 2799 West Grand Boulevard, Detroit, Michigan, U.S.A

    Hani N. Sabbah,  Victor G. Sharov &  Sidney Goldstein

Authors
  1. Hani N. Sabbah
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Victor G. Sharov
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sidney Goldstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sabbah, H.N., Sharov, V.G. & Goldstein, S. Cell Death, Tissue Hypoxia and the Progression of Heart Failure. Heart Fail Rev 5, 131–138 (2000). https://doi.org/10.1023/A:1009880720032

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1009880720032

Keywords

Search

Navigation